800
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Effectiveness of Nigella sativa and Ginger as Appetite Suppressants: An Experimental Study on Healthy Wistar Rats

ORCID Icon, , , , , , , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & show all
Pages 1-11 | Received 04 Nov 2022, Accepted 05 Jan 2023, Published online: 10 Jan 2023

References

  • World Health Organization. Obesity and Overweight. World Health Organization; 2018.
  • Lin X, Li H. Obesity: epidemiology, pathophysiology, and therapeutics. Front Endocrinol. 2021;12:706978.
  • Salem V, AlHusseini N, Abdul Razack HI, Naoum A, Sims OT, Alqahtani SA. Prevalence, risk factors, and interventions for obesity in Saudi Arabia: a systematic review. Obes Rev. 2022;23(7):e13448.
  • Dhurandhar NV, Petersen KS, Webster C. Key causes and contributors of obesity: a perspective. Nurs Clin North Am. 2021;56(4):449–464.
  • Almughamisi M, O’Keeffe M, Harding S. Adolescent obesity prevention in Saudi Arabia: co-identifying actionable priorities for interventions. Front Public Health. 2022;10:863765.
  • Iwamoto SJ, Abushamat LA, Zaman A, Millard AJ, Cornier MA. Obesity management in cardiometabolic disease: state of the art. Curr Atheroscler Rep. 2021;23(10):59.
  • Bamosa AO, Kaatabi H, Lebdaa FM, Elq AM, Al-Sultanb A. Effect of Nigella sativa seeds on the glycemic control of patients with type 2 diabetes mellitus. Indian J Physiol Pharmacol. 2010;54(4):344–354.
  • Salem AM, Bamosa AO, Qutub HO, et al. Effect of Nigella sativa supplementation on lung function and inflammatory mediators in partly controlled asthma: a randomized controlled trial. Ann Saudi Med. 2017;37(1):64–71.
  • Eldalo AS, Alotaibi MN, Alenazi TO, Albogami HA, Mohamed KM. Use of herbal medicines in the treatment of obesity in Taif, Saudi Arabia. Saudi J Med Med Sci. 2017;5(2):149–154.
  • Hadi S, Daryabeygi-Khotbehsara R, Mirmiran P, et al. Effect of Nigella sativa oil extract on cardiometabolic risk factors in type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial. Phytother Res. 2021;35(7):3747–3755.
  • Cheikh-Rouhou S, Besbes S, Hentati B. Nigella sativa L: chemical composition and physicochemical characteristics of lipid fraction. Food Chem. 2007;101:673–681.
  • Dahri AH, Chandiol AM, Rahoo AA, Memon RA. Effect of Nigella sativa (kalonji) on serum cholesterol of albino rats. J Ayub Med Coll Abbottabad. 2005;17(2):72–74.
  • Al Asoom LI. Molecular mechanisms of Nigella sativa- and Nigella sativa exercise-induced cardiac hypertrophy in rats. Evid Based Complementary Altern Med. 2021;2021:5553022.
  • Al Asoom L. Inventor; Imam Abdulrahman Bin Faisal University assignee. Saudi Arabia: Method for effecting angiogenesis by administering Nigella sativa; 2020.
  • Safi S, Razmpoosh E, Fallahzadeh H, et al. The effect of Nigella sativa on appetite, anthropometric and body composition indices among overweight and obese women: a crossover, double-blind, placebo-controlled, randomized clinical trial. Complement Ther Med. 2021;57:102653.
  • Parhizkar S, Latiff LA, Rahman SA, Dollah MA. Preventive effect of Nigella sativa on metabolic syndrome in menopause induced rats. J Med Plant Res. 2011;5(8):1478–1484.
  • Mohtashami A, Entezari MH. Effects of Nigella sativa supplementation on blood parameters and anthropometric indices in adults: a systematic review on clinical trials. J Res Med Sci. 2016;21:3.
  • Zhou X, Afzal S, Wohlmuth H, et al. Synergistic anti-inflammatory activity of ginger and turmeric extracts in inhibiting lipopolysaccharide and interferon-γ-induced proinflammatory mediators. Molecules. 2022;27:12.
  • Deng X, Chen D, Sun X, Dong J, Huang J. Effects of ginger extract and its major component 6-gingerol on anti-tumor property through mitochondrial biogenesis in CD8. J Food Sci. 2022;87:3307.
  • Rasheed N. Ginger and its active constituents as therapeutic agents: recent perspectives with molecular evidences. Int J Health Sci. 2020;14(6):1–3.
  • Ebrahimzadeh Attari V, Malek Mahdavi A, Javadivala Z, Mahluji S, Zununi Vahed S, Ostadrahimi A. A systematic review of the anti-obesity and weight lowering effect of ginger (Zingiber officinale Roscoe) and its mechanisms of action. Phytother Res. 2018;32(4):577–585.
  • Konstantinidi M, Koutelidakis AE. Functional foods and bioactive compounds: a review of its possible role on weight management and obesity’s metabolic consequences. Medicines. 2019;6:3.
  • FDA. Approved medication guide: Saxenda. In: Services TDoHaH. Maryland: The United States Food and Drug Administration (FDA); 2018:1–24.
  • Chao AM, Wadden TA, Walsh OA, et al. Effects of liraglutide and behavioral weight loss on food cravings, eating behaviors, and eating disorder psychopathology. Obesity. 2019;27(12):2005–2010.
  • Whitten JS. Liraglutide (Saxenda) for weight loss. Am Fam Physician. 2016;94(2):161–166.
  • Sternson SM, Eiselt AK. Three pillars for the neural control of appetite. Annu Rev Physiol. 2017;79:401–423.
  • Konturek PC, Konturek JW, Cześnikiewicz-Guzik M, Brzozowski T, Sito E, Konturek SJ. Neuro-hormonal control of food intake: basic mechanisms and clinical implications. J Physiol Pharmacol. 2005;56(Suppl 6):5–25.
  • Andermann ML, Lowell BB. Toward a wiring diagram understanding of appetite control. Neuron. 2017;95(4):757–778.
  • Murphy KG, Bloom SR. Gut hormones in the control of appetite. Exp Physiol. 2004;89(5):507–516.
  • Dhillo WS, Bloom SR. Gastrointestinal hormones and regulation of food intake. Horm Metab Res. 2004;36(11–12):846–851.
  • Charan J, Kantharia ND. How to calculate sample size in animal studies? J Pharmacol Pharmacother. 2013;4(4):303–306.
  • Al-Asoom LI, Al-Shaikh BA, Bamosa AO, El-Bahai MN. Effect of Nigella sativa supplementation to exercise training in a novel model of physiological cardiac hypertrophy. Cardiovasc Toxicol. 2014;14(3):243–250.
  • Al Asoom LI. Coronary angiogenic effect of long-term administration of Nigella sativa. BMC Complement Altern Med. 2017;17(1):308.
  • Wang J, Ke W, Bao R, Hu X, Chen F. Beneficial effects of ginger Zingiber officinale Roscoe on obesity and metabolic syndrome: a review. Ann N Y Acad Sci. 2017;1398(1):83–98.
  • Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res. 2003;17(4):299–305.
  • Abdullahi A, Ahmad K, Ismail IS, et al. Potential of using ginger essential oils-based nanotechnology to control tropical plant diseases. Plant Pathol J. 2020;36(6):515–535.
  • Liberini CG, Koch-Laskowski K, Shaulson E, et al. Combined Amylin/GLP-1 pharmacotherapy to promote and sustain long-lasting weight loss. Sci Rep. 2019;9(1):8447.
  • Hayes MR, Kanoski SE, Alhadeff AL, Grill HJ. Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats. Obesity. 2011;19(7):1342–1349.
  • Bamosa A. Nigella sativa is a safe herbal product. J Integr Med. 2014;12(1):66.
  • Namazi N, Larijani B, Ayati MH, Abdollahi M. The effects of Nigella sativa L. on obesity: a systematic review and meta-analysis. J Ethnopharmacol. 2018;219:173–181.
  • Mahdavi R, Namazi N, Alizadeh M, Farajnia S. Effects of Nigella sativa oil with a low-calorie diet on cardiometabolic risk factors in obese women: a randomized controlled clinical trial. Food Funct. 2015;6(6):2041–2048.
  • Zaoui A, Cherrah Y, Mahassini N, Alaoui K, Amarouch H, Hassar M. Acute and chronic toxicity of Nigella sativa fixed oil. Phytomedicine. 2002;9(1):69–74.
  • Meddah B, Ducroc R, El Abbes Faouzi M, et al. Nigella sativa inhibits intestinal glucose absorption and improves glucose tolerance in rats. J Ethnopharmacol. 2009;121(3):419–424.
  • Mostafa TM, Hegazy SK, Elnaidany SS, Shehabeldin WA, Sawan ES. Nigella sativa as a promising intervention for metabolic and inflammatory disorders in obese prediabetic subjects: a comparative study of Nigella sativa versus both lifestyle modification and metformin. J Diabetes Complications. 2021;35(7):107947.
  • Le PM, Benhaddou-Andaloussi A, Elimadi A, Settaf A, Cherrah Y, Haddad PS. The petroleum ether extract of Nigella sativa exerts lipid-lowering and insulin-sensitizing actions in the rat. J Ethnopharmacol. 2004;94(2–3):251–259.
  • Badar A, Kaatabi H, Bamosa A, et al. Effect of Nigella sativa supplementation over a one-year period on lipid levels, blood pressure and heart rate in type-2 diabetic patients receiving oral hypoglycemic agents: nonrandomized clinical trial. Ann Saudi Med. 2017;37(1):56–63.
  • Moustafa HAM, El Wakeel LM, Halawa MR, Sabri NA, El-Bahy AZ, Singab AN. Effect of Nigella Sativa oil versus metformin on glycemic control and biochemical parameters of newly diagnosed type 2 diabetes mellitus patients. Endocrine. 2019;65(2):286–294.
  • Pradhan G, Samson SL, Sun Y. Ghrelin: much more than a hunger hormone. Curr Opin Clin Nutr Metab Care. 2013;16(6):619–624.
  • Mahmoud RH, Elnour WA. Comparative evaluation of the efficacy of ginger and orlistat on obesity management, pancreatic lipase and liver peroxisomal catalase enzyme in male albino rats. Eur Rev Med Pharmacol Sci. 2013;17(1):75–83.
  • Sayed S, Ahmed M, El-Shehawi A, et al. Ginger water reduces body weight gain and improves energy expenditure in rats. Foods. 2020;9(1):38.
  • Wang J, Li D, Wang P, Hu X, Chen F. Ginger prevents obesity through regulation of energy metabolism and activation of browning in high-fat diet-induced obese mice. J Nutr Biochem. 2019;70:105–115.
  • Imperatore R, Palomba L, Cristino L. Role of orexin-A in hypertension and obesity. Curr Hypertens Rep. 2017;19(4):34.
  • Mehta A, Marso SP, Neeland IJ. Liraglutide for weight management: a critical review of the evidence. Obes Sci Pract. 2017;3(1):3–14.
  • Hyde KM, Blonde GD, le Roux CW, Spector AC. Liraglutide suppression of caloric intake competes with the intake-promoting effects of a palatable cafeteria diet, but does not impact food or macronutrient selection. Physiol Behav. 2017;177:4–12.
  • Manigault KR, Thurston MM. Liraglutide: a glucagon-like peptide-1 agonist for chronic weight management. Consult Pharm. 2016;31(12):685–697.
  • Liberini CG, Lhamo R, Ghidewon M, et al. Liraglutide pharmacotherapy reduces body weight and improves glycaemic control in juvenile obese/hyperglycaemic male and female rats. Diabetes Obes Metab. 2019;21(4):866–875.
  • Valle A, Català-Niell A, Colom B, García-Palmer FJ, Oliver J, Roca P. Sex-related differences in energy balance in response to caloric restriction. Am J Physiol Endocrinol Metab. 2005;289(1):E15–E22.
  • Lightfoot JT. Sex hormones’ regulation of rodent physical activity: a review. Int J Biol Sci. 2008;4(3):126–132.
  • Guevara R, Valle A, Gianotti M, Roca P, Oliver J. Gender-dependent differences in serum profiles of insulin and leptin in caloric restricted rats. Horm Metab Res. 2008;40(1):38–43.
  • Cortright RN, Chandler MP, Lemon PW, DiCarlo SE. Daily exercise reduces fat, protein and body mass in male but not female rats. Physiol Behav. 1997;62(1):105–111.